PS Ratio: 11.04

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 11.04 is 84% below its estimated 5-year average of 67.18, near the low end of its estimated 5-year range (5.67–2150.62).

As of 2026-10-06T15:52:24.237Z. 69.27% below its estimated 12-month average of 35.92.

OBIO PS Ratio Metrics

P/S vs. estimated history

At 11.04, P/S is below its estimated 5-year median — higher than 10% of readings in its estimated 5-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Orchestra BioMed Holdings, Inc. (OBIO)?

The P/S ratio for OBIO stock is 11.04.

Is Orchestra BioMed Holdings, Inc.'s P/S ratio high or low?

The P/S ratio of 11.04 is 84% below its estimated 5-year average of 67.18, near the low end of its estimated 5-year range (5.67–2150.62).

What is the estimated TTM average P/S ratio for Orchestra BioMed Holdings, Inc. (OBIO)?

The estimated TTM average P/S ratio for OBIO stock is 35.92.

What is the estimated 3Y average P/S ratio for Orchestra BioMed Holdings, Inc. (OBIO)?

The estimated 3Y average P/S ratio for OBIO stock is 58.08.

What is the estimated 5Y average P/S ratio for Orchestra BioMed Holdings, Inc. (OBIO)?

The estimated 5Y average P/S ratio for OBIO stock is 67.18.

Showing the most recent 260 of 1,184 data points. The chart above shows the full history.

Related Metrics